MesylatesErgoloid MesylatesAminationPalladiumNational Cancer Institute (U.S.)Therapeutic EquipoisePatient SelectionClinical Trials, Phase III as TopicClinical Trials as TopicMedical OncologyBiostatisticsNeoplasmsResearch DesignBone DensityEarly Termination of Clinical TrialsCancer Care FacilitiesBenchmarkingPatient ParticipationClinical Trials, Phase IV as TopicClinical Trials, Phase II as TopicUnited StatesOrganizational AffiliationBone Development